top of page

Cannabis for Anxiety: Cannabinoids for Childhood Psychiatric Disorders

Welcome to homework assignment CAS 1.10 in the Cannabis for Anxiety seminar from Higher Learning LV. This assignment focuses on the therapeutic application of cannabis for anxiety and, specifically, a 2023 study about the potential efficacy of cannabinoids for childhood neurodevelopmental and neuropsychiatric disorders, including a number of anxiety disorders.

After you complete this assignment, use the button at the bottom to return to the Cannabis for Anxiety seminar master page.


A 2023 Australian study entitled "Efficacy of Cannabinoids in Neurodevelopmental and Neuropsychiatric Disorders Among Children and Adolescents: A Systematic Review" that was published in the journal European Child & Adolescent Psychiatry provided a "systematic review of the rationale and current clinical trial evidence for cannabinoid-based products (CBPs) in the treatment of neuropsychiatric and neurodevelopmental disorders in children and adolescents."

Want to read more?

Subscribe to to keep reading this exclusive post.


Не вдалося завантажити коментарі
Здається, виникли технічні проблеми. Спробуйте оновити сторінку.
bottom of page